EQ Corporate publishes insights on healthcare regulation, market entry, distribution and commercial strategy in Mexico.
Our goal is to provide clear, accurate and useful information for international healthcare companies evaluating or operating in the Mexican market.
This policy explains how we produce and review our content, including how artificial intelligence tools may support selected editorial workflows.
EQ Corporate GmbH holds editorial responsibility for content published on www.eq-corporate.com.
Editorial oversight rests with:
Judith Escobar, Marketing Director, EQ Corporate GmbH
Editorial contact: contact@eq-corporate.com
Content is reviewed and approved before publication. EQ Corporate may update or correct published content when new information or regulatory developments arise.
We follow five principles:
Accuracy. Regulatory and material factual claims are checked against appropriate primary or authoritative sources.
Expertise. Content is written or reviewed by professionals with relevant experience in healthcare regulation, market entry, distribution and commercial strategy in Mexico.
Clarity. We aim to provide precise, practical information that helps decision-makers understand the Mexican healthcare market.
Transparency. We identify authorship and publication or review dates where appropriate, and provide a way for readers to report potential errors.
Accountability. Technology may support our work, but professional judgement, editorial responsibility and accountability remain with EQ Corporate and the professionals involved in reviewing the content.
Our editorial process typically includes:
EQ Corporate may use artificial intelligence tools to support selected editorial and professional workflows.
AI may assist with activities such as research organisation, outlining, drafting, editing, summarisation, translation and content optimisation.
AI-generated output is not treated as an authoritative source for regulatory, legal, cost, timeline or other material factual claims.
Such information is subject to appropriate human review and, where relevant, verification against primary or authoritative sources before publication.
AI tools support our work; they do not replace professional expertise, judgement or editorial accountability.
All substantive editorial content published by EQ Corporate is subject to human oversight, and EQ Corporate GmbH retains responsibility for the final publication.
This approach reflects the human review and editorial control principles established under Article 50 of Regulation (EU) 2024/1689, the EU Artificial Intelligence Act.
AI-generated or materially altered visuals are reviewed before publication.
Where disclosure is required by applicable law, or where visual content could reasonably be mistaken for an authentic representation of a real person, event or circumstance, EQ Corporate will identify it appropriately.
Photographs presented as images of our team, partners, offices or real events are not artificially generated.
EQ Corporate applies its confidentiality, data-protection and information-security requirements when using AI tools.
Personal data, confidential client information and commercially sensitive information are handled in accordance with applicable legal, contractual and data-protection requirements.
Further information on our handling of personal data is available in our Privacy Policy.
For regulatory content, we rely where appropriate on primary and authoritative sources, including:
Where costs, timelines or market conditions vary, we distinguish between official information and observed or estimated ranges when relevant.
Regulatory content is reviewed periodically and updated when significant changes occur.
Articles and guides indicate their publication date and, where appropriate, their last review date.
If we identify a material error, we correct it.
Readers can report potential inaccuracies at: contact@eq-corporate.com
EQ Corporate is a consulting, market-entry and distribution firm specialising in the Mexican healthcare market.
Our content naturally reflects the sectors and issues in which we work, but we do not accept payment for editorial coverage or undisclosed sponsored content.
Relevant commercial relationships are disclosed where appropriate.
Content published by EQ Corporate provides general information about healthcare regulation, market access and commercial matters in Mexico.
Specific requirements depend on factors such as product classification, intended use, regulatory history, documentation and the circumstances of each company.
Our website content does not by itself create a client relationship with EQ Corporate.
Content may be published in English and Spanish.
Translation technology and artificial intelligence tools may assist the translation process, but technical and regulatory content is subject to appropriate human review.
For questions about this policy or to report a potential error, contact: contact@eq-corporate.com